115 related articles for article (PubMed ID: 6121578)
1. Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro.
Hallengren B; Forsgren A; Melander A
Br J Clin Pharmacol; 1982 Apr; 13(4):543-6. PubMed ID: 6121578
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
Kerr D; MacDonald IA; Heller SR; Tattersall RB
Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
[TBL] [Abstract][Full Text] [Related]
3. Effects of atenolol and some other beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts.
Nakasone J; Kato T; Noguchi K; Nagamine F; Sakanashi M
Jpn J Pharmacol; 1988 Aug; 47(4):387-95. PubMed ID: 2903263
[TBL] [Abstract][Full Text] [Related]
4. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism.
Whyte K; Jones CR; Howie CA; Deighton N; Sumner DJ; Reid JL
Eur J Clin Pharmacol; 1987; 32(3):237-43. PubMed ID: 2885202
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lymphocyte capping and transformation by propranolol and related compounds.
Anderton BH; Axford JS; Cohn P; Marshall NJ; Shen L; Sprake S
Br J Pharmacol; 1981 Jan; 72(1):69-74. PubMed ID: 6112036
[TBL] [Abstract][Full Text] [Related]
7. Diazepam/beta-adrenoceptor antagonist interactions.
Hawksworth G; Betts T; Crowe A; Knight R; Nyemitei-Addo I; Parry K; Petrie JC; Raffle A; Parsons A
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):69S-76S. PubMed ID: 6146341
[TBL] [Abstract][Full Text] [Related]
8. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
Boucher M; Duchêne-Marullaz P; Moundanga JL
Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of propranolol on lymphocyte rosette formation and response to plant mitogens.
Dunne JV; Peters CJ; Moore TL; Vaughan JH
Arthritis Rheum; 1978; 21(7):767-73. PubMed ID: 697947
[TBL] [Abstract][Full Text] [Related]
10. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I
Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611
[TBL] [Abstract][Full Text] [Related]
11. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
McDevitt DG; Brown HC; Carruthers SG; Shanks RG
Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by propranolol of 3,5,3'-triiodothyronine formation from thyroxine in isolated rat renal tubules: an effect independent of beta-adrenergic blockade.
Heyma P; Larkins RG; Campbell DG
Endocrinology; 1980 May; 106(5):1437-41. PubMed ID: 6102511
[TBL] [Abstract][Full Text] [Related]
14. The thyroid function and size in healthy man during 3 weeks treatment with beta-adrenoceptor-antagonists.
Kayser L; Perrild H; Feldt-Rasmussen U; Hegedüs L; Skovsted L; Hansen JE
Horm Metab Res; 1991 Jan; 23(1):35-7. PubMed ID: 1673110
[TBL] [Abstract][Full Text] [Related]
15. Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment.
Michel MC; Pingsmann A; Beckeringh JJ; Zerkowski HR; Doetsch N; Brodde OE
Br J Pharmacol; 1988 Jul; 94(3):685-92. PubMed ID: 2902891
[TBL] [Abstract][Full Text] [Related]
16. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
Perucca E; Pickles H; Richens A
Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
[TBL] [Abstract][Full Text] [Related]
17. beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays rat cutaneous wound healing.
Romana-Souza B; Santos JS; Monte-Alto-Costa A
Wound Repair Regen; 2009; 17(2):230-9. PubMed ID: 19320892
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
19. Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway.
Nicholson AN; Wright NA; Zetlein MB; Currie D; McDevitt DG
Br J Clin Pharmacol; 1988 Aug; 26(2):129-41. PubMed ID: 2905149
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenoceptor antagonists and human sperm motility.
Curtis-Prior PB; Gadd AL
J Pharm Pharmacol; 1990 Mar; 42(3):220-2. PubMed ID: 1974626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]